Hello and a Warm Welcome to MedX, In this episode, we cover the most recent FDA approvals shaping the future of medical treatments: Durvalumab – Approved for muscle-invasive bladder cancer as neoadjuvant and adjuvant therapy. Cabozantinib – Approved for pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 and older. Fitusiran – Appr
2028 Reached
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Black Lesion in Old Female
1963 Reached5 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes